Dr. Pourhassan has said he acquired the company in 2012... I've held unyielding, crap OTCs since 2012 so anyone who's been in this long, kudos to you!!! Think though the length of time one holds is insignificant if a start-up actually comes through, the way something as real as Leronlimab is proving to be... and a life saver to boot, WOW!

While I realize Leronlimab (Vyrologix) was relatively really close to getting to market, think this tragic CV-19 took over and paved the way to much more... the reputation of these companies has grown and strengthened exponentially (CytoDyn-Dr. Pourhassan, IncellDX-Dr. patterson, Quest Clinical Research-Dr. Lalezari)... I'm naming these particular men but as we all know, it takes teams and lots of folks to brainstorm and do the legwork necessary... my hat's off to all of them!!!

Side note: In my short (long) eight years in OTC and even long (longer) 30+ years in the markets (regarding particular securities I've been involved in/with) I have never before seen a PR come out like the one this morning in terms of timing or should I say in the middle of the night (1:24, really?)... ahaha